New MRD Assessment Data Using clonoSEQ® To Be Presented at 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress

Read More

Kyle Piskel

Chief Financial Officer

Kyle Piskel is the Chief Financial Officer at Adaptive Biotechnologies, a commercial-stage biotech company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease. Since joining Adaptive in 2015, Kyle has held various positions of ascending responsibility within finance and accounting, including Corporate Controller and Principal Accounting Officer. Prior to joining Adaptive, Kyle worked at Expedia Group and Ernst & Young, LLP.  Kyle is a Certified Public Accountant.